Compare AstraZeneca plc (AZN) vs Capital One Financial Corp. (COF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Capital One Financial Corp. — how do they compare? AstraZeneca plc trades at $158.2 (market cap $248.14B), while Capital One Financial Corp. trades at $219.37 (market cap $134.45B). The key difference: AstraZeneca plc is the larger of the two by market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | COF | |
|---|---|---|
Market Cap | $248.14B | $134.45B |
Sector | Health | Financials |
52-Week High | $209.48 | $257.94 |
52-Week Low | $147.06 | $176.10 |
Enterprise Value | $275.41B | — |
Dividend Yield | 2.01% | 1.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Capital One Financial Corp.
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Read more on COF →
